相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC
Sridurga Mithraprabhu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
HDAC6 promotes hepatocellular carcinoma progression by inhibiting P53 transcriptional activity
Gang Ding et al.
FEBS LETTERS (2013)
HDAC11 is a novel drug target in carcinomas
Hedwig E. Deubzer et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The functional interactome landscape of the human histone deacetylase family
Preeti Joshi et al.
MOLECULAR SYSTEMS BIOLOGY (2013)
Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
Loredana Santo et al.
BLOOD (2012)
HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance
Michael Van Damme et al.
EPIGENETICS (2012)
Histone deacetylases and cancer
Bruna Barneda-Zahonero et al.
MOLECULAR ONCOLOGY (2012)
Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms
Vibe Skov et al.
LEUKEMIA & LYMPHOMA (2012)
The genetic architecture of multiple myeloma
Gareth J. Morgan et al.
NATURE REVIEWS CANCER (2012)
The Role of HDAC6 in Cancer
Grace I. Aldana-Masangkay et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Regulating the Regulators: The Post-Translational Code of Class I HDAC1 and HDAC2
Chiara V. Segre et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis
Andrea Clocchiatti et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Mechanism of Action of Proteasome Inhibitors and Deacetylase Inhibitors and the Biological Basis of Synergy in Multiple Myeloma
Teru Hideshima et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Initial genome sequencing and analysis of multiple myeloma
Michael A. Chapman et al.
NATURE (2011)
Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma
Jiro Kikuchi et al.
BLOOD (2010)
Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia
Daniel Antunes Moreno et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
The DAC system and associations with multiple myeloma
Enrique M. Ocio et al.
INVESTIGATIONAL NEW DRUGS (2010)
HDAC expression and clinical prognosis in human malignancies
Wilko Weichert
CANCER LETTERS (2009)
HDAC family: What are the cancer relevant targets?
Olaf Witt et al.
CANCER LETTERS (2009)
Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas
Lena Marquard et al.
HISTOPATHOLOGY (2009)
Expression Levels of Histone Deacetylases Determine the Cell Fate of Hematopoietic Progenitors
Taeko Wada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance
Alejandro Villagra et al.
NATURE IMMUNOLOGY (2009)
The many roles of histone deacetylases in development and physiology: implications for disease and therapy
Michael Haberland et al.
NATURE REVIEWS GENETICS (2009)
HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism
D. Mottet et al.
ONCOGENE (2009)
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
W. Weichert et al.
BRITISH JOURNAL OF CANCER (2008)
Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer:: Specific role of class I histone deacetylases in vitro and in vivo
Wilko Weichert et al.
CLINICAL CANCER RESEARCH (2008)
Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma
L. Marquard et al.
HISTOPATHOLOGY (2008)
HDAC4 Promotes Growth of Colon Cancer Cells via Repression of p21
Andrew J. Wilson et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer:: a retrospective analysis
Wilko Weichert et al.
LANCET ONCOLOGY (2008)
Enhanced histone deacetylase enzyme activity in primary myelofibrosis
Jen Chin Wang et al.
LEUKEMIA & LYMPHOMA (2008)
Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas
Wilko Weichert et al.
NEOPLASIA (2008)
Histone deacetylases and cancer
M. A. Glozak et al.
ONCOGENE (2007)
Molecular characterization of human multiple myeloma cell lines by integrative genomics: Insights into the biology of the disease
Luigia Lombardi et al.
GENES CHROMOSOMES & CANCER (2007)
Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma
Tatsuya Rikimaru et al.
ONCOLOGY (2007)
Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast
ZH Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Molecular pathogenesis and a consequent classification of multiple myeloma
PL Bergsagel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer
S Saji et al.
ONCOGENE (2005)
Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma
T Hideshima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
International staging system for multiple myeloma
PR Greipp et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases
K Mimori et al.
EJSO (2005)
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
MF Fraga et al.
NATURE GENETICS (2005)
Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes
N Yoshida et al.
CANCER SCIENCE (2004)
Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients
H Osada et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
HDAC6 expression is correlated with better survival in breast cancer
ZH Zhang et al.
CLINICAL CANCER RESEARCH (2004)
Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response
GD Kao et al.
JOURNAL OF CELL BIOLOGY (2003)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma
YP Shou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
